SPRI | Bone Drugs In Pediatrics: Efficacy And Challenges (2014 EN)

Discussion in 'Medicine' started by Kanka, Jan 4, 2018.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,395
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Gordon Klein (Editor)
    Full Title: Bone Drugs In Pediatrics: Efficacy And Challenges
    Publisher: Springer; 2014 edition (April 3, 2014)
    Year: 2014
    ISBN-13: 9781489974365 (978-1-4899-7436-5), 9781489974358 (978-1-4899-7435-8), 9781489978486 (978-1-4899-7848-6)
    ISBN-10: 1489974369, 1489974350, 1489978488
    Pages: 233
    Language: English
    Genre: Medicine: Internal Medicine
    File type: PDF (True)
    Quality: 10/10
    Price: 128.39 €


    Bone Drugs in Pediatrics brings together in one place the evidence for the use of certain drugs in the treatment and prevention of bone loss in children, as well as the reservations still present in the pediatric community regarding their use. Beginning with a discussion of developmental pharmacokinetics and drug development for pediatric diseases where bone loss occurs, such as osteogenesis imperfecta, the physiology of pediatric bone and how best to monitor the safety and efficacy of these drugs is presented. The pros and cons of utilizing the drugs themselves – such as bisphosphonates, antiresorptives and anabolic agents – within the pediatric population are carefully considered, with an eye toward safe and effective integration. The potential use of drugs in future treatment is also highlighted. On the whole, Bone Drugs in Pediatrics is a cogent presentation of the ongoing debate surrounding the potential for pharmacological interventions in pediatric bone loss.

    -------------
     
    Last edited by a moderator: Nov 30, 2019